Jessica E. Parker, MD
Assistant Professor of Clinical Obstetrics & Gynecology
Associate Program Director, Gynecologic Oncology Fellowship Program
- jesepark@iu.edu
- Address
-
FH 204
OBGY
Indianapolis, IN 46202
Bio
Dr. Jessica Parker is an Assistant Professor in the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology. She is also the Associate Program Director for the Gynecologic Oncology fellowship opening in 2026. Since starting at IU, she has been awarded the Shepard Chair and the national APGO Excellence in Teaching Award. She is an active member of the Society of Gynecologic Oncology, Heartland Association of Gynecologic Oncology as well as NRG Oncology. Dr. Parker also serves on multiple national and local committees. She has submitted several research grants and is the ovarian cancer primary investigator site lead for clinical trials at IU.
Dr. Parker joined IU Health as a gynecologic oncologist in September 2021. She chose to be an oncologist at a very young age after experiencing the loss of a loved one to cancer. Gynecologic Oncology provides her the opportunity to create a bond with patients and their families through all aspects of their care including through surgery, chemotherapy, radiation, palliative care and during remission. While Dr. Parker is interested in all aspects of gynecologic oncology, her research interests are specifically in ovarian cancer, cancer survivorship and clinical trials. She performs complex open, laparoscopic, and robotic surgery for ovarian, uterine, cervical, vulvar and vaginal cancers.
Dr. Parker earned her MD at the University of Florida College of Medicine in 2013. She completed her residency training in obstetrics and gynecology at Stony Brook University in New York in 2017 and her fellowship in gynecologic oncology at University of Texas Southwestern in 2021.
Key Publications
Aljardali MW, Kremer KM, Parker JE, Fleming E, Chen H, Lea JS, Kraus LW, Camacho CV. Nucleolar localization of the RNA Helicase DDX21 Predicts Survival Outcomes in Gynecological Cancers. Cancer Res Commun. 2024 May 20. doi: 10.1158/2767-9764. PMID: 38767454
Parker JE, Yoshida EJ, Gien LT, Slomovitz BM, Nagel C. Vulvar cancer management and wrangling recurrent disease: A Report from the Society of Gynecologic Oncology Journal Club. Gynecol Oncol Rep. 2023 Nov 28; 50:101310. doi: 10.1016/j.gore.2023.PMID: 38093798
Yu X, Lin W, Spirtos A, Wang Y, Chen H, Ye J, Parker JE, Liu C, Wang Y, Quinn G, Zhou F, Chambers SK, Lewis C, Lea JS, Li B, Zheng W. Dissection of transcriptome dysregulation and immune characterization in women wiht germline BRCA1 mutation at single-cell resolution. BMC Med. 2022 Sept 9; 20:283. PMID: 36076202
Parker JE, Maurer MA, Zheng W, Miller DS, Lea JS. Lynch syndrome identification in patients with Type 1 and Type II endometrial cancers: Should universal screening be used for all histologic subtypes? Curr Womens Health Rev. 2021;17:1-0. https://doi.org/10.2174/1573404817666210302153551
Parker JE, Miller DS, Lee J, Carlson M, Lococo S, Lea JS. SGO Survey: Current Practice Patterns in Nodal Evaluation and Adjuvant Treatment of Advanced Stage Endometrioid Endometrial Cancer. Gyneco Onco Rep. 2020 Aug 7;34:100620. PMID:32939389
| Year | Degree | Institution |
|---|---|---|
| 2021 | Fellowship | University of Texas Southwestern Medical Center |
| 2017 | Residency | Stony Brook Medicine |
| 2013 | MD | University of Florida |
| 2010 | BS | University of Florida |
Dr. Parker's research interests include ovarian cancer, cancer survivorship and clinical trials. She is a primary investigator site lead for cancer clinical trials at IU.
- Ovarian cancer clinical trials
- Musculoskeletal health in ovarian cancer survivors
- Gut microbiome in cancer survivors
- Health disparities
Clinical interests include treating gynecological cancers. She performs complex open, laparoscopic, and robotic surgery for ovarian, uterine, cervical, vulvar and vaginal cancers.